Samsung Biologics secures $223 million contract with Baxter Healthcare

Samsung Biologics said Tuesday that it has signed a contract manufacturing organization (CMO) agreement worth 234.1 billion won ($208 million, based on USD/KRW 1,124.90 on July 21, 2017) with U.S. Baxter Healthcare Corporation.
Read more...